Jinhe金河品牌怎么样 申请店铺

外推网助力Jinhe金河品牌出海！通过在本页面挂载Jinhe金河品牌的产品链接和联系邮箱，可以提高Jinhe金河产品曝光！跨境电商爆单神器，目前只要100元/年哦~

金河生物科技股份有限公司是一家生产和销售饲用金霉素及动物保健品为主的民营控股企业，1998年被国家科委认定为“国家重点高新技术企业”，同时也是内蒙古自治区60家重点企业之一。

公司位于青山南麓、黄河之滨的内蒙古托克托县境内，与亚洲最大的火力发电厂——大唐托克托电厂比邻相依，并与中国最大的露天煤矿——准格尔煤田隔（黄）河相望，具有得天独厚的地理优势和资源优势。

公司现拥有国际上先进的发酵生产设备和产品质量检测设备，主要工艺流程全部采用微机自动控制，现有发酵吨位5794立方米，金霉素的发酵规模居世界前列。

其主导产品“牧星”、“金河”牌饲用金霉素目前年生产能力5.3万多吨，连续六次顺利通过美国联邦政府食品与药品管理总署（FDA）的质量验收。

产品主要出口到美国、加拿大、东南亚等国家和地区，同时行销网络遍布国内各省、市（自治区），市场前景十分广阔。

作为一家高新技术企业，金河生物科技股份有限公司近年来得到了迅猛的发展，这主要得益于企业以人为本的发展思路和强大的技术支撑。

通过人才的引进和人力资源的合理配置，使企业逐步形成了自己的人才梯队，在充分发挥人才优势的群体效应的同时，在生产技术领域不断地完善与创新，为企业在知识经济时代异军突起奠定了坚实的基础。

良好的信誉、卓越的品质源于企业严格的管理和对技术创新孜孜不倦的追求。

2001-2002年，企业先后顺利通过了ISO9002质量体系认证和国家兽药企业GMP验收。

从1994年起，企业连续六次顺利通过美国联邦政府食品药品管理总署（FDA）的质量验收，并被国家九部委认定为农业产业化国家重点龙头企业。

金河生物科技股份有限公司在未来的发展进程中，将按照“面向市场、优化结构、整合资源、提高效益”的发展构想，以发酵工业为载体，以调整产品结构为主线，走外延与内涵相结合扩大再生产的科技强企之路，通过与行业精英联盟，实现资产优化和管理升级，结合基因工程等高科技手段的探索与研究，全面提升企业的整体素质和核心竞争力，进一步增强企业的经济实力和发展后劲，为民族工业的繁荣和发展做出新的更大的贡献。

Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly engaged in the production and sale of feed chlortetracycline and animal health products. In 1998, it was recognized as a "national key high-tech enterprise" by the State Science and Technology Commission, and also one of the 60 key enterprises in Inner Mongolia Autonomous Region. The company is located in Tuoketuo County, Inner Mongolia, on the south foot of Qingshan mountain and the Bank of the Yellow River. It is adjacent to Datang Tuoketuo Power Plant, the largest thermal power plant in Asia, and across the (yellow) River from Jungar coal field, the largest open-pit coal mine in China. It has unique geographical advantages and resource advantages. The company now has advanced fermentation production equipment and product quality testing equipment in the world. The main technological process is all controlled by computer automatically. The current fermentation tonnage is 5794 cubic meters, and the fermentation scale of chlortetracycline ranks the top in the world. Its leading products "muxing" and "Jinhe" brand feed aureomycin currently have an annual production capacity of more than 53000 tons, and have successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times. The products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions. At the same time, the marketing network is all over the domestic provinces, cities (autonomous regions), and the market prospect is very broad. As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the people-oriented development ideas and strong technical support of the enterprise. Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon. While giving full play to the group effect of talent advantages, it has constantly improved and innovated in the field of production technology, laying a solid foundation for the emergence of enterprises in the era of knowledge economy. Good reputation and excellent quality come from the strict management of the enterprise and the tireless pursuit of technological innovation. From 2001 to 2002, the company has successfully passed ISO9002 quality system certification and GMP acceptance of national veterinary drug enterprises. Since 1994, the company has successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times, and has been recognized as the national key leading enterprise of agricultural industrialization by nine ministries and commissions. In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "facing the market, optimizing the structure, integrating the resources and improving the efficiency", take the fermentation industry as the carrier, adjust the product structure as the main line, take the road of expanding the renewable production through the combination of extension and connotation, and realize the asset optimization and management upgrading through the alliance with the industry elite, Combined with the exploration and research of high-tech means such as genetic engineering, we will comprehensively improve the overall quality and core competitiveness of enterprises, further enhance the economic strength and development potential of enterprises, and make new and greater contributions to the prosperity and development of national industry.

本文链接： https://brand.waitui.com/cc6e5eebb.html 联系电话：请联系客服添加